MARKET

PRQR

PRQR

Proqr Therapeuti
NASDAQ
2.000
+0.010
+0.50%
Opening 15:04 05/03 EDT
OPEN
1.990
PREV CLOSE
1.990
HIGH
2.050
LOW
1.970
VOLUME
201.95K
TURNOVER
0
52 WEEK HIGH
3.290
52 WEEK LOW
1.110
MARKET CAP
162.71M
P/E (TTM)
-5.2206
1D
5D
1M
3M
1Y
5Y
GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
NASDAQ · 2d ago
Weekly Report: what happened at PRQR last week (0422-0426)?
Weekly Report · 4d ago
ProQR Therapeutics Announces Board Nomination and AGM
TipRanks · 04/23 11:27
BRIEF-ProQR Therapeutics NV Intends To Change Board Structure From Two-Tier Structure To One-Tier Board
Reuters · 04/23 11:24
PROQR NOMINATES MARTIN MAIER, PHD TO BOARD AND ANNOUNCES ANNUAL MEETING OF SHAREHOLDERS TO BE HELD MAY 22, 2024
Reuters · 04/23 11:00
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
ProQR Therapeutics will present new preclinical data for its Axiomer™ RNA editing technology platform at the American Society of Gene & Cell Therapy Annual Meeting, May 7-11, 2024. ProQR is a company dedicated to changing lives through transformative RNA therapies.
Barchart · 04/22 15:31
Weekly Report: what happened at PRQR last week (0415-0419)?
Weekly Report · 04/22 12:11
ProQR Solidifies Lead in RNA Therapy Innovation
TipRanks · 04/19 11:27
More
About PRQR
ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).

Webull offers ProQR Therapeutics NV stock information, including NASDAQ: PRQR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRQR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRQR stock methods without spending real money on the virtual paper trading platform.